LMAM
BIO icon

Legg Mason Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Legg Mason Asset Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$700K Sell
927
-46
-5% -$34.4K 0.77% 64
2021
Q3 		$726K Sell
973
-79
-8% -$59.2K 0.84% 55
2021
Q2 		$678K Buy
+1,052
New +$640K 0.74% 70

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Legg Mason Asset Management's BIO Position: Q4 2021 in Review

Legg Mason Asset Management reduced its Bio-Rad Laboratories Class A (BIO) stake by 4.7% in Q4 2021, selling an estimated $34.4K and leaving 927 shares worth $700K. The position accounts for 0.77% of the portfolio, ranked #64.

Legg Mason Asset Management first reported a position in BIO in Q2 2021 and has held it in 3 quarters since. The position peaked at $726K in Q3 2021. 533 funds tracked by Wall St. Rank hold BIO as of Q4 2021.

  • Legg Mason Asset Management held 927 shares of Bio-Rad Laboratories Class A worth $700K as of Q4 2021.
  • Legg Mason Asset Management sold 46 Bio-Rad Laboratories Class A shares in Q4 2021, an estimated $34.4K.
  • Bio-Rad Laboratories Class A made up 0.77% of Legg Mason Asset Management's portfolio in Q4 2021, its #64 holding.
  • Legg Mason Asset Management first reported a position in Bio-Rad Laboratories Class A in Q2 2021 and has held it in 3 quarters since.
  • Legg Mason Asset Management's Bio-Rad Laboratories Class A position peaked at $726K in Q3 2021.
  • 533 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2021.

Based on Legg Mason Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.